Flu season is near – here’s a guide to available vaccines

Flu activity is ticking up earlier than usual in parts of the western United States, though national surveillance still shows low activity as of late September. The CDC classified last season as moderately severe, with over 32 million cases and up to 81,000 deaths, partly attributed to low vaccination rates and a poor vaccine match.

This season brings several options: standard shots, high-dose versions for seniors, the FluMist nasal spray, egg-free Flucelvax, and a brand-new mRNA vaccine called mFLUSIVA approved for adults 50 and up. All three vaccine components were updated to better match expected circulating strains, and health authorities recommend vaccination for nearly everyone six months and older.

The full dispatch is available from the source below.